Indian Pharma Market (IPM) - Major Highlights of May 2015 ........................................................................................ IPM clocked 7717 Crs in May 2015 IPM grew at 11.0% for the month of May 2015 ............................................................................................... Top IPM Companies: Among the top 10, Sun grew by 19.9% followed by Cipla at 15.4% & Abbott at 13.2% ............................................................................................ 23 companies crossed the growth of IPM in May among top 50 ....................................................................................... In the top 50, Akumentis had the highest growth of 29.1% followed by Glenmark at 28.9% & Torrent at 27.0 % ........................................................................................... 25 Companies grew at more than 10% among the top 50 ................................................................................................ Among the 11-20 ranked, Glenmark has the highest growth of 28.9% followed by Torrent at 27.0% & Aristo at 21.7% ........................................................................................... Among the 21-30 ranked, MSD* had the highest growth at 23.9% followed by Wockhardt 21.2% & Alembic at 15.1% ..................................................................................................... Among the 31-40 ranked, Akumentis has the highest growth at 29.1% followed by Merck at 21.3% & Bharat Serums at 18.7% ................................................................................................ Among the 41-50 ranked, Allergan has the highest growth at 26.8% followed by Wallace at 11.6% & Apex at 11.5% ............................................................................. Among the 51-60 ranked, Eli Lilly grew at 34.4% followed by Troikaa at 27.0% & Centaur at 23.7% ..................................................................................... Among the 61-70 ranked, Boehringer grew at 61.1% followed by Fresenius Kabi grew by 53.9% followed by RPG at 29.6% .................................................................................. Glenmark enters the 2000 Cr mark, Natco 100 Crs on MAT Basis ....................................................................................... Indian Vs. MNCs Indian companies grew at 11.2% Vs. 10.2% for MNCs in May 2015 .................................................................................................. Among the top 50 in MNCs, Allergan grew by 26.8% followed by MSD* at 23.9% & Merck at 21.3% ................................................................................... Under the Non-NLEM category Indian Companies grew at 4.7% whereas MNCs grew at 6.9% .................................................................................... DPCO, Non DPCO & Non-Scheduled Para 19 Market: DPCO containing molecules market grew at

1. A PharmaTrac Overview
MAY 15

2. Dataset : PharmaTrac MAT MAY 2015 (Val in Crs)(Val in Crs)
JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY
2012 - 13 5738 6019 6422 6566 6548 5991 5912 5853 5713 5803 6389 6226
2013 - 14 6087 6678 6565 6536 6554 6518 6492 6487 6110 6159 6871 6955
2014 - 15 6906 7366 7293 7866 7031 7293 7427 7310 7239 7430 8070 7717
6.1
10.9
2.2 -0.5 0.1 8.8 9.8 10.8
6.9 6.1
7.5 11.713.4
10.3 11.1
20.4
7.3
11.9
14.4 12.7 11.5 20.6
17.4
11.0
4500
5000
5500
6000
6500
7000
7500
8000
8500
INDUSTRY DYNAMICS: IPM grows consecutive at double digit for last 7 months…..

3. Dataset : PharmaTrac MAT MAY 2015 (Val in Crs)(Val in Crs)
7688
5395
4228
3466
2743 2938
3036
2908 2604 2460
203
105
245
240
447
206 34 48
53 166
14.0
12.5
17.6
8.5
16.7
13.1
4.3
14.7
17.1
27.6
0.0
5.0
10.0
15.0
20.0
25.0
30.0
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
SUN* ABBOTT* CIPLA ZYDUS* MANKIND ALKEM* GSK LUPIN PFIZER* MACLEODS
AV BV GR
TOP CORPORATES: Sun* grows at 14%…8 out of Top 10 grow in double
digits….. Macleods at 27.6% fastest in top 10……

4. Dataset : PharmaTrac MAT MAY 2015 (Val in Crs)(Val in Crs)
BONUS CONTRIBUTION: 3.7% Bonus to Industry Turnover
SV- Sales Val
BV- Bonus Val
 Maximum Bonus given by Mankind followed Aristo, Cipla, and Zydus*.
 Other companies which have high bonus component are Alkem*(205Crs) and Sun* (203Crs)
 Mankind Bonus Contribution has gone down a period of time.
SV AV BV CORPORATE SV AV BV GR % CONTRI TO BONUS BV % TO SV
0 0 0 IPM 88948 85701 3247 14.0 100.0 3.7
1 1 6 SUN* 7891 7688 203 14.0 6.2 2.6
2 2 8 ABBOTT* 5500 5395 105 12.5 3.2 1.9
3 3 3 CIPLA 4474 4228 245 17.6 7.6 5.5
4 4 4 ZYDUS* 3706 3466 240 8.5 7.4 6.5
5 8 1 MANKIND 3191 2743 447 16.7 13.8 14.0
6 6 5 ALKEM* 3144 2938 206 13.1 6.4 6.6
7 5 22 GSK 3070 3036 34 4.3 1.0 1.1
8 7 15 LUPIN 2955 2908 48 14.7 1.5 1.6
9 9 13 PFIZER* 2656 2604 53 17.1 1.6 2.0
10 10 7 MACLEODS 2626 2460 166 27.6 5.1 6.3
RANK MAT MAY 15

5. Dataset : PharmaTrac MAT MAY 2015 (Val in Crs)(Val in Crs)
May-14 May-15
MAT VAL MS GR CORPORATE MAT VAL MS GR
78010.3 100.00 6.6 IPM 88947.7 100.00 14.0
34389 44.08 5.3 TOP 10 39213 44.09 14.0
21733 27.86 8.1 11 - 25 25040 28.15 15.2
10393 13.32 11.2 26 - 50 11860 13.33 14.1
7088 9.09 7.2 51 - 100 7938 8.92 12.0
4408 5.65 -1.0 100 + 4897 5.51 11.1
44.08
27.86
13.32
9.09
5.65
May-14
TOP 10 11 - 25 26 - 50 51 - 100 100 +
44.09
28.15
13.33
8.92
5.51
May-15
TOP 10 11 - 25 26 - 50 51 - 100 100 +
Koye, Jubilant, Delcure, Saffron Therapeutics are the newer players…..

6. Dataset : PharmaTrac MAT MAY 2015 (Val in Crs)(Val in Crs)
GR
IPM SUN* ABBOTT* CIPLA ZYDUS* MANKIND ALKEM* GSK LUPIN PFIZER* MACLEODS
16.5 17.5 14.5 17.4 10.9 20.5 11.2 6.9 19.0 16.1 38.8
13.0 11.4 11.2 17.8 7.6 16.0 13.3 3.9 11.0 17.3 23.6
69.8
56.1 59.4 59.0
70.4
83.2
90.8 86.7
52.4
85.2
71.4
30.2
43.9 40.6 41.0
29.6
16.8
9.2 13.3
47.6
14.8
28.6
IPM SUN* ABBOTT* CIPLA ZYDUS* MANKIND ALKEM* GSK LUPIN PFIZER* MACLEODS
ACUTE CHRONIC
Acute – Chronic Split: Both the Splits in double digits……

7. Dataset : PharmaTrac MAT MAY 2015 (Val in Crs)(Val in Crs)
* Abbott + Abbott HC + Novo; Alkem + Indchemie + Cachet; Pfizer + Wyeth; Zydus + Biochem; Micro + Bal
MAT VAL MAY 15
ZONE MAT VAL MS MS (G / L) GR INCRE VAL
IPM 88948 100.00% 0.00% 14.0 10937
SOUTH ZONE 23888 26.86% -0.26% 12.9 2737
NORTH ZONE 22998 25.86% -0.32% 12.6 2582
WEST ZONE 20727 23.30% 0.20% 15.0 2706
EAST ZONE 18167 20.42% 0.25% 15.4 2431
ALL INDIA ONLY 3169 3.56% 0.12% 18.0 483
28%
27%
24%
21%
May-14
SOUTH ZONE NORTH ZONE WEST ZONE EAST ZONE
28%
27%
24%
21%
May-15
SOUTH ZONE NORTH ZONE WEST ZONE EAST ZONE
Zonal Split: South Dominates……West adds up……

8. Dataset : PharmaTrac MAT MAY 2015 (Val in Crs)(Val in Crs)
MAT VAL MAY 15 MS
SUPERGROUP SV BV GR INCRE VAL BV % TO SV SV BV
IPM 88948 3247 14.0 10937 3.7 100.00 100.00
ANTI-INFECTIVES 14054 1097 10.7 1357 7.8 15.80 33.80
CARDIAC 11021 97 13.7 1327 0.9 12.39 2.99
GASTRO INTESTINAL 10290 360 16.1 1426 3.5 11.57 11.07
VITAMINS / MINERALS / NUTRIENTS 8060 183 13.4 952 2.3 9.06 5.63
RESPIRATORY 7010 261 14.2 871 3.7 7.88 8.04
ANTI DIABETIC 6942 42 25.7 1417 0.6 7.80 1.29
PAIN / ANALGESICS 6190 230 12.2 672 3.7 6.96 7.10
NEURO / CNS 5351 42 11.0 530 0.8 6.02 1.30
DERMA 5195 121 17.8 787 2.3 5.84 3.73
GYNAECOLOGICAL 4418 370 9.1 369 8.4 4.97 11.38
VACCINES 1484 55 4.7 67 3.7 1.67 1.70
HORMONES 1477 11 7.7 105 0.8 1.66 0.35
ANTI-NEOPLASTICS 1453 2 23.5 276 0.2 1.63 0.08
OPHTHAL 1302 11 17.4 193 0.9 1.46 0.35
OTHERS 998 34 22.5 183 3.4 1.12 1.05
BLOOD RELATED 992 18 8.2 75 1.8 1.12 0.56
UROLOGY 961 14 25.6 196 1.5 1.08 0.43
ANTI MALARIALS 550 84 4.8 25 15.4 0.62 2.60
SEX STIMULANTS / REJUVENATORS 483 199 8.3 37 41.2 0.54 6.13
STOMATOLOGICALS 380 9 12.7 43 2.2 0.43 0.26
OPHTHAL / OTOLOGICALS 228 1 7.9 17 0.5 0.26 0.04
OTOLOGICALS 107 4 11.2 11 4.0 0.12 0.13
THERAPY SPLIT: Anti Infectives leads & Anti Diabetic grows fast with
highest Incremental gain from Gastro..

9. Dataset : PharmaTrac MAT MAY 2015 (Val in Crs)(Val in Crs)
TOP 20 BRANDS: Mixtard rules…Skinlite enters top 20… Janumet &
Spasmoproxyvon Plus grows well
RANK May-15
May-15 G/L BRAND SUBGROUP CORPORATE SV AV BV GR INCRE
0 0 IPM 88948 85701 3247 14.0 10937
1 0 MIXTARD HUMAN PREMIX ABBOTT* 400 398 2 15.7 54
2 1 AUGMENTIN AMOXYCILLIN + CLAVULANIC ACID GSK 330 330 0 29.9 76
3 1 GLYCOMET GP GLIMEPIRIDE + METFORMIN USV 302 301 1 26.9 64
4 4 MONOCEF CEFTRIAXONE ARISTO 277 193 84 24.4 54
5 1 BECOSULES VITAMIN B COMPLEX WITH VITAMIN C ONLY PFIZER* 253 247 6 11.1 25
6 -1 COREX CHLORPHENIRAMINE + CODEINE PFIZER* 235 234 1 1.9 4
7 5 LANTUS GLARGINE SANOFI INDIA 230 229 1 31.3 55
8 1 CLAVAM AMOXYCILLIN + CLAVULANIC ACID ALKEM* 225 192 33 7.1 15
9 2 DEXORANGE FERROUS COMBINATION FRANCO 213 201 12 19.6 35
10 -3 VOLINI DICLOFENAC SUN* 209 188 21 -6.4 -14
11 68 JANUMET SITAGLIPTIN + METFORMIN MSD* 205 203 2 126.0 115
12 43 SPASMO PROXYVON PLUS DICYCLOMINE + PARACETAMOL + TRAMADOL WOCKHARDT 201 201 0 86.1 93
13 3 PHENSEDYL COUGH LINCTUS CHLORPHENIRAMINE + CODEINE ABBOTT* 200 200 0 25.3 41
14 11 GALVUS MET VILDAGLIPTIN + METFORMIN NOVARTIS 194 193 2 32.9 48
15 0 BETADINE POVIDONE IODINE WIN-MEDICARE 188 182 6 10.8 18
16 5 TAXIM CEFOTAXIME ALKEM* 187 170 16 22.9 35
17 6 SKINLITE HYDROQUINONE + MOMETASONE + TRETINOIN ZYDUS* 186 177 9 24.5 37
18 -8 MANFORCE SILDENAFIL MANKIND 185 53 131 2.2 4
19 -5 LIV 52 HEPATIC PROTECTORS INCLUDING AYURVEDIC HIMALAYA 184 184 0 8.3 14
20 -1 TAXIM O CEFIXIME ALKEM* 179 178 1 15.3 24

10. Dataset : PharmaTrac MAT MAY 2015 (Val in Crs)(Val in Crs)
5108 Brands launched in last 24 months…
May-15
BRAND SUBGROUP COMPANY LD MAT VAL INCRE VAL
NI BRANDS(LAST 24 MONTHS) 3133 2338
SPASMO PROXYVON PLUS DICYCLOMINE + PARACETAMOL + TRAMADOL WOCKHARDT Jul-13 201 93
BIOVAC V VARICELLA VACCINE WOCKHARDT Dec-14 44 44
TRESIBA DEGLUDEC ABBOTT* Oct-13 35 21
DYNAPAR QPS DICLOFENAC TROIKAA Jun-13 26 17
HYOCIMAX HYOSCINE ZYDUS* Jan-14 24 15
MOX CV AMOXYCILLIN + CLAVULANIC ACID SUN* Jan-14 23 19
GLIMISAVE MV VOGLIBOSE + METFORMIN + GLIMEPIRIDE ERIS Jul-13 23 13
HEALTH OK MULTIVITAMINS + MINERALS MANKIND Aug-13 20 14
TRAJENTA DUO METFORMIN + LINAGLIPTIN BOEHRINGER INGELHEIM Jan-14 19 18
GERBISA BISACODYL ZYDUS* Jan-14 19 9
DULCOFLEX BISACODYL BOEHRINGER INGELHEIM Jan-14 19 17
COMBIMIST L LEVOSALBUTAMOL + IPRATROPIUM ZYDUS* Jun-13 16 7
MEROBAX MEROPENEM ARISTO Dec-13 16 12
FERINJECT IRON FERRIC LUPIN Feb-14 16 13
DOXT SL DOXYCYCLINE + LACTOBACILLUS DR. REDDYS Jun-14 15 15
NEWBONA ACTIVE CALCIUM + CHOLECALCIFEROL AKUMENTIS Jul-13 15 4
TAVERA PIPERACILLIN + TAZOBACTAM IKON REMEDIES PVT LTD Jul-14 15 15
MELBILD DECA PEPTIDE+ISOPROPYL ALCOHOL+MYRISTATE+GLYCOL ALKEM* Apr-14 14 13
LIPAGLYN SAROGLITAZAR ZYDUS* Sep-13 14 9
CANMAB TRASTUZUMAB BIOCON Feb-14 14 13